15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200
Sign in 0

GHRP-6 5mg

$18.99 or subscribe for $15.99/mo

Lot PL-2609-039 tested in our lab: 99.14% purity by HPLC Certificate PL-26-00039, analysed Sep 19, 2026 · LC-MS identity, endotoxin and sterility on the certificate · details and COA images
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Safety data sheet PL-SDS-064 GHS: not classified as hazardous · Read the SDS · PDF

Visa, Mastercard, Discover up to $1,000 per order (charged in MXN; your bank may add a foreign-transaction fee). Pay by Bank, Zelle, Cash App or crypto: 10% off.

GHRP-6 5 mg: the six-residue growth hormone secretagogue His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 as freeze-dried powder in a sealed vial, made as its own lot. Tested in PrymaLab’s own laboratory, with a lot certificate. Laboratory research use only.

Description

PrymaLab · Research use only

GHRP-6 5mg

GHRP-6 as 5 mg of freeze-dried powder, the smaller of the two vial fills

GHRP-6 is a synthetic six-residue peptide that releases growth hormone through the growth hormone secretagogue receptor, the receptor ghrelin also binds. This vial contains 5 mg of freeze-dried GHRP-6, half the 10 mg main fill, produced and tested as a separate lot. Most research on GHRP-6 concerns its pituitary action, first characterised in the 1980s, and the receptor work that followed.

Specifications

GHRP-6 5mg at a glance
Property Value
Compound GHRP-6 Growth hormone-releasing peptide-6
CAS number 87616-84-0
Molecular formula C46H56N12O6
Theoretical mass 873.0 Da
Sequence / structure H-H-[D-Trp]-A-W-[D-Phe]-K-NH₂ (6 residues; C-terminal amide)
Label claim 5 mg/vial
Form Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap
Storage, sealed −20 °C, desiccated, dark
Purity specification 99.0% or higher by RP-HPLC
Lot certificate Results for the lot now shipping are in the certificate panel on this page
Safety data sheet PL-SDS-064

Other fills

This is the 5 mg fill. The GHRP-6 10mg page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 10 mg.

What the research covers

A 1998 review by Bowers described the growth hormone-releasing peptides as acting on both the hypothalamus and the pituitary, two complementary sites, and argued that they reflect a natural hypothalamic hormone that had not then been identified1. In the first human study, GHRP-6 raised growth hormone in healthy men in proportion to the amount, with no change in LH, FSH, TSH or ACTH2. The full research summary, from the 1984 discovery to the cloning of the receptor, is on the GHRP-6 10 mg vial page.

The GHRP-2 vs GHRP-6 guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

Does the 5 mg vial hold the same GHRP-6 as the 10 mg?

Yes. The sequence is His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, with a C-terminal amide and a theoretical mass of 873.0 Da, in both fills. Each fill is made as its own lot, so check the lot number on the vial against its own certificate.

How much GHRP-6 is in the vial in molar terms?

About 5.7 µmol, worked out from the theoretical mass of 873.0 Da. Because the powder also contains some residual water, reported as a percentage on the certificate, the true peptide content is slightly below that figure.

How is the sealed vial stored?

At −20 °C, desiccated and dark. GHRP-6 carries two tryptophan residues, so light protection matters for the powder and for any solution made from it, which should be kept at 2 to 8 °C.

References

  1. Bowers CY. Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci. 1998;54(12):1316-29. DOI · PubMed
  2. Ilson BE, Jorkasky DK, Curnow RT, et al. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab. 1989;69(1):212-4. DOI · PubMed

Research use only

For laboratory research use only. GHRP-6 5mg is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of GHRP-6

GHRP-6 is also stocked as GHRP-6 10mg Nasal Spray and GHRP-6 10mg preloaded 3ml pen. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.

Additional information

Weight 0.1 lbs
Dimensions N/A

Lot PL-2609-039 · Certificate of Analysis PL-26-00039

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

CompoundGHRP-6
Growth hormone-releasing peptide-6
CAS number87616-84-0
Molecular formulaC46H56N12O6
Theoretical mass873.0 Da
Sequence / structureH-H-[D-Trp]-A-W-[D-Phe]-K-NH₂ (6 residues; C-terminal amide)
AppearanceWhite lyophilized powder
Storage−20 °C, desiccated, dark
Label claim5 mg/vial
Lot numberPL-2609-039
Certificate numberPL-26-00039
Date of analysis2026-09-19 (retest 2028-09-18)
Purity (RP-HPLC)99.14%
Identity (LC-MS)872.8 Da
Water content (KF)1.6%
Endotoxin (LAL)0.04 EU/mg
SterilityNo growth; conforms
ConclusionPASS
Tested byPrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Certificate of analysis for lot PL-2609-039, page 1
Certificate page 1: results
Certificate of analysis for lot PL-2609-039, page 2
Certificate page 2: method and approval

Safety data sheet PL-SDS-064 · GHRP-6

GHS safety data sheet for this product (lyophilized powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Not classified as hazardous Not classified under OSHA HCS 2012 / GHS. No pictogram, signal word or hazard statement is required; handle as a pharmacologically active laboratory chemical.
CompositionGHRP-6 (CAS 87616-84-0) · ≥ 95% (dry basis, as supplied), 5 mg, 10 mg per vial
ClassificationNot classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Physical stateSolid. White to off-white lyophilized powder.
Storage−20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
HandlingOpen vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

Side by side comparison of GHRP-2 and GHRP-6 peptide vials next to a chart showing growth hormone release and appetite stimulation effects.

GHRP-2 vs GHRP-6: Selectivity and Receptor Data

GHRP-2 and GHRP-6 are ghrelin-receptor agonists that trigger growth hormone release. This guide compares their receptor pharmacology, potency, effects on appetite signalling and the side effects reported in studies.

Infographic: Sermorelin vs Ipamorelin vs Tesamorelin vs CJC-1295

Sermorelin vs Ipamorelin vs Tesamorelin: Key Differences

Every comparison question in this category has the same answer underneath it. These four compounds split into two groups hitting two different receptors, and once you know which group a compound belongs to, most of the confusion clears. What is left is a half-life spread running from ten minutes to eight days.

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

7-day returns on unopened, sealed products, plus our third-party testing guarantee.

Shipping truck icon
Free US shipping

Free USA shipping over $100 and free worldwide shipping over $200.

RealReviews.io Rate your experience with PrymaLab